NASSIF DAVID W. (Principal Financial Officer) received a stock award from SIO GENE THERAPIES INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/15/2020ACC: 0001209191-20-036808
Officer· Principal Financial Officer
Since Jul 2019
-5.27K
Net shares
Net seller
$17.1K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
15.06K acquired · 20.33K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
+15.06K
Price / share
—
Trade value
—
% of position
164.6%
6/11/2020
9.15K→24.21K
Common Shares
Direct
Shares
−5.27K
Price / share
$3.25
Trade value
$17.11K
% of position
21.8%
6/11/2020
24.21K→18.94K
Total
Net shares
+9.79K
Net value
-$17.11K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 6/11/2020 | A · Award | +15.06K | — | — | 164.6% | 9.15K | 24.21K |
| Common Shares Direct | 6/11/2020 | F · Tax Withholding | −5.27K | $3.25 | $17.11K | 21.8% | 24.21K | 18.94K |
| Total | +9.79K | -$17.11K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Shares
15.06K shares
Shares
−15.06K
Strike price
Held after
15.06K
Exercisable
—
6/12/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Shares15.06K shares | 6/12/2020 | D · Disposition | −15.06K | — | 15.06K |